Nuwellis (NUWE) News Today $0.83 -0.13 (-13.54%) Closing price 03:59 PM EasternExtended Trading$0.86 +0.04 (+4.22%) As of 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Nuwellis, Inc. (NASDAQ:NUWE) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | msn.comNuwellis price target lowered to $13 from $16 at Roth MKMMarch 11, 2025 | markets.businessinsider.comNuwellis, Inc. (NUWE) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comNuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial ResultsMarch 11, 2025 | globenewswire.comNuwellis Appoints John Erb as Interim CEOFebruary 25, 2025 | msn.comNuwellis CEO Nestor Jaramillo retires, John Erb named interim CEOFebruary 25, 2025 | markets.businessinsider.comNuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEOFebruary 24, 2025 | globenewswire.comNuwellis’ Aquadex SmartFlow therapy shows heart failure reduction in studyFebruary 21, 2025 | markets.businessinsider.comJACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study AnalysisFebruary 20, 2025 | globenewswire.comNuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025February 18, 2025 | globenewswire.comNuwellis says CMS reimbursement for Aquadex ‘quadrupled,’ shares jumpJanuary 31, 2025 | markets.businessinsider.comFDA issues “high-risk” safety alert to Nuwellis blood circuit setsDecember 31, 2024 | finance.yahoo.comFDA says aware Nuwellis recalling certain blood circuit lotsDecember 30, 2024 | markets.businessinsider.comNuwellis regains Nasdaq compliance with bid and equity rulesDecember 21, 2024 | uk.investing.comNuwellis, Inc. Regains Compliance with Nasdaq's Minimum Bid Price and Equity RequirementsDecember 21, 2024 | nasdaq.comNuwellis, Inc.: Nuwellis Regains Compliance with Nasdaq Listing RequirementsDecember 19, 2024 | finanznachrichten.deNuwellis Regains Compliance with Nasdaq Listing RequirementsDecember 19, 2024 | globenewswire.comNuwellis files to sell 3.73M shares of common stock for holdersNovember 16, 2024 | markets.businessinsider.comQ3 2024 Nuwellis Inc Earnings CallNovember 12, 2024 | finance.yahoo.comNuwellis, Inc. (NASDAQ:NUWE) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comNuwellis, Inc. (NUWE) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | seekingalpha.comNuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent HighlightsNovember 11, 2024 | globenewswire.comExamining the Future: Nuwellis's Earnings OutlookNovember 9, 2024 | benzinga.comNuwellis announces exercise of warrants for $5.1M in gross proceedsNovember 6, 2024 | markets.businessinsider.comNuwellis tumbles on exercise of warrants to raise $5.1MNovember 6, 2024 | msn.comNuwellis Announces Exercise of Warrants for $5.1 Million of Gross ProceedsNovember 5, 2024 | globenewswire.comNuwellis Stock Spikes After Reimbursement Hike: Retail’s UpbeatNovember 5, 2024 | msn.comNuwellis receives increased reimbursement rate for Aquadex SmartFlow therapyNovember 4, 2024 | markets.businessinsider.comNuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex SystemNovember 4, 2024 | finance.yahoo.comNuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and MedicaidNovember 4, 2024 | globenewswire.comNuwellis Shares Surge Following Preliminary 3Q ResultsNovember 1, 2024 | marketwatch.comNuwellis Announces Preliminary Results for Third Quarter of 2024November 1, 2024 | globenewswire.comNuwellis announces University of Iowa Health Care as newest customerOctober 31, 2024 | markets.businessinsider.comNuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric CustomerOctober 31, 2024 | markets.businessinsider.comNuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric CustomerOctober 31, 2024 | globenewswire.comSeastar Medical settles dispute with Nuwellis for $900KOctober 24, 2024 | investing.comNuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024October 23, 2024 | globenewswire.comNuwellis to Present at the Third Annual ROTH Healthcare Opportunities ConferenceSeptember 25, 2024 | globenewswire.comRoth MKM Keeps Their Buy Rating on Zevra Therapeutics (ZVRA)September 24, 2024 | markets.businessinsider.comNuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq RulesAugust 23, 2024 | globenewswire.comNUWE Stock Earnings: Nuwellis Beats EPS, Beats Revenue for Q2 2024August 14, 2024 | msn.comNuwellis, Inc. (NASDAQ:NUWE) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comNuwellis, Inc. Announces Second Quarter 2024 Financial ResultsAugust 13, 2024 | globenewswire.comNuwellis Q2 Earnings PreviewAugust 12, 2024 | msn.comNuwellis earnings preview: what to expectAugust 12, 2024 | markets.businessinsider.comNasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to ConditionsAugust 8, 2024 | finance.yahoo.comRoth MKM Initiates Coverage of Nuwellis (NUWE) with Buy RecommendationJuly 30, 2024 | msn.comWhy Nuwellis Stock Is ClimbingJuly 30, 2024 | msn.comCatalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earningsJuly 27, 2024 | msn.comNuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical’s QUELIMMUNE™ Therapy at Cincinnati Children’sJuly 26, 2024 | finance.yahoo.com Remove Ads Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address NUWE Media Mentions By Week NUWE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUWE News Sentiment▼1.000.61▲Average Medical News Sentiment NUWE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUWE Articles This Week▼11▲NUWE Articles Average Week Remove Ads Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NRXS News ALUR News QTI News PETV News SSKN News ICU News DHAI News POAI News BSGM News INBS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUWE) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.